Summary:
Chennai: Glioblastoma multiforme (also called glioblastoma) is the most common and aggressive form of primary brain tumour and it's the most common type of malignant brain tumour among adults. Now researchers have developed a new glioma-targeted nano-therapeutic that will only address tumour cells offering increased effectiveness and reduced side effects. Published in Advanced Healthcare Materials the study reported a new glioma-targeted nano-therapeutic that will only address tumour cells offering increased effectiveness and reduced side effects. Because the IL13 receptors are abundant she added IL13 ligands onto her FDA-approved biodegradable polymer carrier (with the Dp44mT inside) so the receptors would lure the ligands thus receiving the medicine. Now with our targeted delivery we put an address on the package and it goes directly to the cancer cells” said Majd..